Inoviv
Accelerating the Development of New Medicines with Targeted Proteomics
London, United Kingdom
34 employees
Venture round
Biopharma, Biotechnology +3
General Information
London, United Kingdom
BounceWatch is an independent company data service, not affiliated with Inoviv. To contact Inoviv, visit inoviv.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United Kingdom Market
Biopharma
About Inoviv
Taxonomy: proteomics, biomarker, pharmaceuticals, technology platform, drug development, biomedical research, diagnostics, innovation, precision medicine
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | Undisclosed | 2 |
|
30 Jan 2024 |
| Seed Round | Undisclosed | 3 |
|
06 Jun 2021 |
| Seed Round | Undisclosed | 1 |
|
01 Jan 2019 |
Inoviv Alternatives & Competitors
View All Alternatives
Innovative biomarker solutions for improved diagnostics, enhancing patient outcomes and optimizing h...
A Novel Biomarker Discovery Solution for Personalized Drug Development Denovo Biopharma is a priva...
-logo.jpg "Lantern Pharma Inc. (Nasdaq: LTRN)"){kind=logo}
Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies
FAQ About Inoviv
Source: BounceWatch company record for Inoviv, https://bouncewatch.com/company/inoviv, updated 24 October 2024. When citing, please name BounceWatch and link this page.
